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Maladaptive dopaminergic mediation of reward processing in
humans is thought to underlie multiple neuropsychiatric disorders,
including addiction, Parkinson’s disease, and schizophrenia. Mech-
anisms responsible for the development of such disorders may
depend on individual differences in neural signaling within large-
scale cortico-subcortical circuitry. Using a combination of functional
neuroimaging and pharmacological challenges in healthy volunteers,
we identified opposing dopamine agonistic and antagonistic neuro-
modulatory effects on distributed functional interactions between
specific subcortical regions and corresponding neocortical “resting-
state” networks, known to be involved in distinct aspects of cognition
and reward processing. We found that, relative to a placebo, levodopa
and haloperidol challenges, respectively, increased or decreased the
functional connectivity between (1) the midbrain and a “default
mode” network, (2) the right caudate and a right-lateralized frontopar-
ietal network, and (3) the ventral striatum and a fronto-insular
network. Further, we found drug-specific associations between brain
circuitry reactivity to dopamine modulation and individual differences
in trait impulsivity, revealing dissociable drug–personality interaction
effects across distinct dopamine-dependent cortico-subcortical net-
works. Our findings identify possible systems underlying pathogenesis
and treatment efficacy in disorders of dopamine deficiency.
Keywords: dopamine, functional connectivity, impulsivity, pharmacological
FMRI, resting-state networks
Introduction
Dopamine neurotransmission is intimately and consistently
linked with reward-seeking and impulsive behaviors (Pessi-
glione et al. 2006; Buckholtz et al. 2010). Specific neurorecep-
tor proteins regulating dopaminergic signaling are thought to
mediate individual differences in sensitivity to pharmacologi-
cal manipulation and, accordingly, the probability of develop-
ing and sustaining symptoms of pathological reward,
inhibitory, or salience processing in disorders such as addic-
tion, Parkinson’s disease, and schizophrenia (Schafer et al.
2001; Dalley et al. 2007; Dagher and Robbins 2009; Buckholtz
et al. 2010). It has been hypothesized further that the
complex cognitive processes and personality factors relevant
for reward-related behavior and impulsivity are mediated
by large-scale neuronal systems, communicating via cortico-
subcortical pathways (Koob and Volkow 2010). Evidence
suggests that dopaminergic influences in the brain can be
investigated through functional magnetic resonance imaging
(FMRI) of analogous networks (Honey et al. 2003). However,
broad-spectrum dopaminergic manipulations of cortico-
subcortical connections within multiple large-scale networks
and, moreover, interactions with individual difference
measures relevant for psychopharmacological modulation of
pathological processing have not yet been investigated.
With FMRI, communication between remote neuronal
populations at the systems level can be probed via measures
of synchronization over time, or “functional connectivity,”
between spatially distinct blood-oxygenation level-dependent
(BOLD) signals (Biswal et al. 1995; Smith et al. 2009; Lee
et al. 2010). Specifically, pharmacological FMRI research
demonstrates that measures of connectivity between distribu-
ted brain regions are sensitive to the effects of dopaminergic
challenge, using agonist or antagonist drugs that either in-
crease or decrease neurotransmission (Honey et al. 2003;
Achard and Bullmore 2007; Kelly et al. 2009; Tost et al. 2010).
Our study used BOLD FMRI to investigate in detail the func-
tional connectivity relationships between subcortical regions
known to comprise core dopaminergic transmission pathways
(Pessiglione et al. 2006; Buckholtz et al. 2010; Koob and
Volkow 2010) and multiple, distributed neocortical networks
thought to underlie specific aspects of cognition (e.g. Greicius
et al. 2004; Beckmann et al. 2005; Seeley et al. 2007).
Measured during undirected wakefulness, these systems are
known as “resting-state” networks (RSNs) and comprise the
fundamental functional architecture of the human brain
(Beckmann et al. 2005; Smith et al. 2009; Biswal et al. 2010).
We focussed specifically on RSNs relevant for cognitive
control, impulsivity, and reward processing (Seeley et al. 2007;
Smith et al. 2009; Cole et al. 2010; Koob and Volkow 2010;
Shannon et al. 2011), which have also been implicated as dys-
functional in neuropsychiatric disorders regularly treated with
dopamine-targeting medications (e.g. Castellanos et al. 2008;
Kelly et al. 2009; Wolf et al. 2011). Through a novel combi-
nation of multivariate and univariate FMRI data analysis tech-
niques, along with “clinical” fixed-dose dopamine agonistic
(100 mg levodopa; L-dopa) and antagonistic (3 mg haloperi-
dol) pharmacological challenges, we were able to map in
healthy humans the dopamine-dependent architecture of sub-
cortical functional connectivity with these RSNs and, further,
to relate variability in drug effects on these systems-level
connectivity patterns to individual differences in impulsivity.
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Materials and Methods
Participants and Study Design
We recruited 55 healthy male volunteers, naive to the experimental
drugs, who were assigned randomly to 3 groups (L-dopa, haloperidol,
or placebo). Data are reported from 49 participants who completed
the study in full (mean age = 22.4 years ± 4.1 SD; Table 1). Eligibility
criteria were: no current (or history of) psychiatric problems as deter-
mined by the Mini-International Neuropsychiatric Interview (Sheehan
et al. 1998); no medical history indicating a risk in using L-dopa or
haloperidol (e.g. cardiac illness, depressive disorders, thyroid dis-
orders, and glaucoma); and no current or recent use (<12 weeks
before participation) of psychopharmacological medication and other
medications or psychotropic drugs that might interfere with the
central nervous system action of L-dopa or haloperidol (e.g. cannabis
or cocaine). Each participant gave signed, informed consent in which
confidentiality, anonymity, and the opportunity to withdraw without
penalty were assured.
Participants received a fixed dose of 3 mg haloperidol (Haldol;
N = 18) 4 h prior to scanning (Tmax = 3–6 h, half-time = 14–36 h) or
100 mg levodopa combined with 25 mg carbidopa (Sinemet; N = 16)
1 h prior (Tmax = 45 min, half-time = 1–2 h) or placebo (N = 15). Drug
administration was double-blind and followed a previously published,
“placebo-counterbalanced” protocol (Pessiglione et al. 2006), ensur-
ing that resting-state FMRI data were acquired at projected peak
plasma concentrations for both drugs. All tablets were over-
encapsulated to ensure that participants and experimenters were
blind to the dosages and could not compare or identify the drugs.
The study was approved by the Medical Ethics Committee of the
Leiden University Medical Center and carried out in accordance with
the standards of the Declaration of Helsinki.
Questionnaires
Participants completed questionnaires immediately after ingestion of
the first pill. To assess individual differences in impulsivity, the
Barratt Impulsiveness Scale (BIS-11; Patton et al. 1995) was adminis-
tered to all subjects (Table 1; data absent for a single subject in the
L-dopa group).
Image Acquisition
Imaging was carried out on a 3 T Achieva MRI scanner (Philips, Best,
The Netherlands) using an 8-channel SENSE head coil. A T1-weighted
structural volume was acquired for registration purposes. For the
resting-state FMRI scan, 220 whole-brain volumes of T2*-weighted
gradient echo planar images (EPIs) sensitive to BOLD contrast were
obtained in the axial direction (repetition time = 2.2 s, echo time = 30 ms,
flip angle = 80°, isotropic voxels of 2.75 mm, slice gap = 0.25 mm,
38 slices). Participants were instructed to remain awake with their eyes
closed throughout.
Image Preprocessing
Resting-state FMRI data were preprocessed and initially analyzed in
individual subject/session-level EPI space. Image preprocessing was
performed with tools from the FMRIB Software Library (FSL; www.
fmrib.ox.ac.uk/fsl; Smith et al. 2004). The first 4 volumes were
removed from each FMRI data set to allow for magnetic equilibration,
resulting in a 216-data point BOLD time series at each voxel per
session. Preprocessing techniques applied to these data included
motion correction, brain extraction, spatial smoothing with a Gaus-
sian kernel of 5 mm full width at half maximum, and high-pass
temporal filtering at 100 s.
Seed-based “partial” correlation analysis (SBCA; O’Reilly et al.
2010) was carried out separately for each subject within an anatomi-
cally derived subcortical seed mask incorporating regions with estab-
lished dopamine-dependent functionality or connectivity (Honey
et al. 2003; Kelly et al. 2009; Buckholtz et al. 2010; Koob and Volkow
2010). Every voxel within each “individualized” subcortical seed
mask was tested quantitatively in terms of its connectivity with each
of a number of RSN “target” maps, which collectively covered the
majority of neocortex.
To construct subject-specific subcortical seed masks, T1 structural
images were segmented using FSL FIRST. Bilateral regions included
in these masks were the entire striatum (comprising regions of
caudate, putamen, and ventral striatum), globus pallidus, amygdala,
hippocampus, and thalamus (and midbrain, discussed subsequently).
The unthresholded versions of these segmented structures (i.e.
without boundary correction; Patenaude et al. 2011) were combined
into a single, “liberal” mask image for each subject. To include mid-
brain voxels within our masks, we carried out nonlinear warp trans-
formation (as implemented in FSL FNIRT) of 6 binary, bilateral
volumes from the Talairach Daemon atlas (Lancaster et al. 2000;
labels =midbrain, substantia nigra, subthalamic nucleus, red nucleus,
mammillary body, and medial geniculate body) to the high-resolution
space of each subject. This midbrain information was then added to
the mask containing subjects’ other subcortical regions. These
subject-specific combined masks were then affine-registered to EPI
space using FSL FLIRT and used in subsequent subject-wise SBCA, to
quantify subcortical functional connectivity with neocortical RSNs.
To construct RSN masks for use as target neural functional connec-
tivity networks at the subject level in SBCA, we obtained 20 binary
RSN spatial maps (7 of interest and 13 “nuisance,” see Higher-Level
Analysis) from a probabilistic group independent component analysis
(ICA) of the subjects given placebo. Placebo data only were entered
into probabilistic multisession ICA with temporal concatenation (as
implemented in FSL MELODIC; Beckmann and Smith 2004; Beck-
mann et al. 2005), to avoid biasing this spatial target selection toward
the larger haloperidol group. This group ICA approach decomposed
the concatenated 4-D data set (216 volumes per scan × 15 subjects =
3240 image volumes) into spatial maps of structured component
signals in the data (and associated time courses), identifying com-
ponent maps, including RSNs, displaying consistent spatiotemporal
coherence within scans and maximal spatial independence across
subjects. The number of components for the data set was estimated
automatically using the Laplace approximation to the Bayesian evi-
dence for the model order in a probabilistic principal component
model (for details, see Beckmann and Smith 2004). We identified 43
independent components in total in the placebo group FMRI data.
Twenty of these were selected for further analyses based on their
neuroanatomical configurations and neurophysiological feasibility as
RSNs, in comparison with previous literature (Beckmann et al. 2005;
Kiviniemi et al. 2009; Smith et al. 2009; Cole et al. 2010). The remain-
ing 23 components were deemed artifacts of motion, non-neuronal
physiology, or magnetic susceptibility (Kiviniemi et al. 2009) and thus
not included in further analyses. Networks identified by the group
ICA and entered into further analyses have been described previously
by multiple groups and comprise core systems and subsystems impli-
cated in multiple sensory, motor, and cognitive functions (Biswal
et al. 1995; Vincent et al. 2006, 2008; Seeley et al. 2007; Smith et al.
2009; Andrews-Hanna et al. 2010; Cole et al. 2010). All 20 template
RSN maps were thresholded (at z > 3), then binarized, and trans-
formed from MNI152 “standard” space (Montreal Neurological Insti-
tute, McGill University, Quebec, Canada) to the data space of each
subject’s EPI session via FLIRT affine registration: first via the space of
the associated high-resolution T1 structural scan and then to func-
tional EPI space. In high-resolution space (prior to registration to EPI
space), voxels with less than 20% probability of containing gray
matter in the equivalent T1 structural (as calculated using FSL FAST)
were removed from all “subject-specific” RSN spatial maps.
Table 1
Descriptive statistics of subject variables for each drug group and associated 1-way analysis of
variance results
Haloperidol
(N= 18)
Placebo
(N= 15)
L-dopa (N= 16;
15 for BIS-11)
F (P)
Age (mean ± SD) 22.25 ± 3.53 21.47 ± 3.05 23.38 ± 5.30 0.86 (0.43)
BIS-11 total (mean ± SD) 66.06 ± 6.46 63.53 ± 9.01 66.67 ± 11.58 0.51 (0.61)
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Analysis of Neocortical RSN Connectivity with Subcortical
Regions
In SBCA, the subcortical seed masks from each subject were examined
individually, in EPI space, for their voxel-wise spatial distributions of
functional connectivity strength with the characteristic activity of each
of the 20 RSNs (7 subjected to higher-level analysis and 13 nuisance).
All 20 non-artifactual components from group ICA were included in
this first-level analysis to ensure that potential extraneous interactions,
or temporally overlapping relationships, between any of the 7 RSNs of
interest (see Higher-Level Analysis; Fig. 1A–G) and any of the 13 nui-
sance RSNs (e.g. visual, auditory, or somatosensory networks) could
be factored out of the analysis, in effect treating the latter as confound
regressors. Voxel-wise connectivity strengths were quantified by calcu-
lating partial correlation coefficients between the BOLD signal time
series at each mask voxel and that of the weighted principal eigenvari-
ate associated with each RSN (the latter calculated via subject-wise prin-
cipal component analyses; O’Reilly et al. 2010). Voxel-wise coefficients
are termed partial because the analysis associated with a given target
RSN controlled, in turn, for the seed voxel’s activity relationship with
each of the other 19 RSNs examined as targets in separate correlation
analyses. In these analyses, we also controlled for the confounding
influences of structured noise from white matter (WM) and cerebrosp-
inal fluid (CSF) tissue types and residual motion artifacts. To this end,
binary T1-segmented maps of WM and CSF (calculated using FSL
FAST) were registered to EPI space using FLIRT and, for each session,
used as masks against the associated, preprocessed functional data
sets, in order to extract confound time series that were calculated as the
mean BOLD signal within these tissue masks. In addition to the WM
and CSF confounds, 6 time series resulting from the motion correction
procedure describing individual subject head motion parameters were
also regressed out of the SBCA.
Higher-Level Analysis
Further analyses examining drug effects on RSN-subcortical functional
connectivity focussed on a subset of 7 RSNs (Fig. 1A–G) of interest
due to their reported involvement in higher cognitive control and
motivational processes potentially relevant for impulse control,
reward processing, or dopamine function (Greicius et al. 2004;
Vincent et al. 2006, 2008; Seeley et al. 2007; Kelly et al. 2009; Smith
et al. 2009; Andrews-Hanna et al. 2010; Cole et al. 2010, 2011; Koob
and Volkow 2010; Shannon et al. 2011; Wolf et al. 2011). In line with
this literature, these RSNs are here referred to as the (1) anterocentric
and (2) posterocentric subsystems of the “default mode” network
(DMN), (3) left- and (4) right-lateralized frontoparietal networks
(FPNs), (5) fronto-insular and (6) dorsal medial–lateral frontal
salience/executive networks (SENs), and (7) the hippocampal-
parietal/ventral DMN.
Figure 1. RSNs of interest and group subcortical seed mask. (A–G) Seven RSNs subjected to higher-level post-SBCA analysis of dopamine-dependent subcortical functional
connectivity. (A) Posterocentric DMN, (B) right-lateralized FPN, (C) inferior fronto-insular SEN, (D) hippocampal-parietal/ventral DMN, (E) anterocentric DMN, (F) left-lateralized
FPN, and (G) dorsal medial–lateral frontal SEN. (H) Subcortical mask used in higher-level analyses. Axial and coronal slices are presented in radiological orientation (left = right).
Table 2
Clusters displaying significant linear effects of dopamine modulation on RSN functional
connectivity: spatial information and associations with impulsivity
RSN (Fig. 1) Subcortical
cluster
anatomical
location
Cluster MNI x, y, z
coordinates (peak
t-statistic) and
volume
Association
between drug
and
RSN-subcortical
connectivity
Association with
BIS-11 scores
(A)
Posterocentric
DMN
Midbrain
(bilateral
posterior)
−6, −28, −6
(5.08), 1680 mm3
Linear: L-dopa
(>placebo)
> haloperidol
Significant negative
correlation in
haloperidol group;
significantly different
from L-dopa group
(B) Right FPN Right dorsal
caudate
12, 8, 6 (4.08),
1656 mm3
L-dopa
(>placebo)
> haloperidol
Positive trend in
haloperidol group;
close-to-significantly
different from placebo
group
(C) Fronto-
insular SEN
Left ventral
striatum
−16, 12, −10
(4.21), 1160 mm3
L-dopa
(>placebo)
> haloperidol
n.s.
(F) Left FPN Bilateral
ventro-medial
thalamus
6, −14, 2 (4.00),
1392 mm3
L-dopa
(>placebo)
> haloperidol
n.s.
Note: n.s., none significant.
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To test the correlation maps resulting from SBCA for
between-group differences (7 RSNs × 49 subjects = 343 maps), they
were transformed to a common stereotactic space, first by affine regis-
tration to high-resolution structural space and then by FNIRT non-
linear warp transform to the MNI152 template space. Correlation
maps were then arranged in a single 4-D file per RSN, containing, for
each subject, a subcortical map of connectivity with said RSN (thus
49 per RSN). These RSN-specific subcortical connectivity maps were
then analyzed within the framework of the general linear model,
using nonparametric permutation testing (5000 permutations; as
implemented in FSL randomise) to identify subcortical regions in
which functional connectivity with a given RSN of interest differed
between dopamine drug treatment groups, in terms of being more
strongly or weakly positive or negative. Explicitly, we hypothesis-
tested for linear drug effects on RSN-subcortical connectivity (L-dopa
> placebo > haloperidol and the inverse contrast). Significant effects
were defined by cluster-mass thresholding (t = 2.3, P < 0.05) with
family-wise error (FWE) correction for multiple comparisons across
the group subcortical mask and are presented in Table 2. For the
group subcortical mask used in these analyses, to be inclusive and to
allow for small intersubject structural variations, we nonlinearly
warped the subcortical masks from each subject to MNI152 space
(using FSL FNIRT), summed them, and then binarized the resulting
image (Fig. 1H).
Measuring Associations Between Connectivity and Impulsivity
To examine drug-specific network functional connectivity associ-
ations with impulsivity, FMRI results were correlated, within-group,
with subject BIS-11 total scores. Significant clusters identified from
the post-SBCA higher-level analysis were thus used as masks to
extract mean connectivity scores from normalized (Fisher’s
z-transformed) versions of the RSN-specific correlation maps initially
used as inputs to higher-level analyses. The resulting values were
then grouped by drug condition and correlated (Pearson’s r) with
BIS-11 total scores to find significant within-group associations
(P < 0.05, 2-tailed). We then compared these correlations across
groups to investigate drug–personality interactions, by testing for sig-
nificant differences between the resulting (Fisher’s z-transformed)
correlation coefficients.
Figure 2. Significant linear effects of antagonistic (haloperidol) and agonistic (L-dopa) dopaminergic neuromodulation on cortico-subcortical RSN functional connectivity and
correlations with subject BIS-11 impulsivity scores. (A) (i) DMN-midbrain connectivity shows (ii) a linear effect (t> 2.3, P<0.05, corrected) of treatment (L-dopa > placebo >
haloperidol), which (iii) is negatively correlated with impulsivity within the haloperidol group, differentially to within the L-dopa group. (B) (i) Right FPN-caudate connectivity shows
(ii) a similar linear effect and (iii) a trend toward an opposite relationship with impulsivity to the DMN-midbrain result. (C) (i) SEN-ventral striatum connectivity shows (ii) the
same linear drug effect but (iii) no significant interaction with impulsivity. Left panels: RSNs presented in orange and subcortical regions in green. Centre panels: box plots
represent mean connectivity scores (±95% confidence intervals) for each drug group. Right panels: **significant within-group correlation with impulsivity (P< 0.05); *significant
difference between 2 correlation coefficients (P< 0.05); and †near-significant trend toward difference between coefficients (P<0.07).
4 Dopamine, Network Connectivity, and Impulsivity • Cole et al.
 at U
niversiteit Tw
ente on A
pril 11, 2013
http://cercor.oxfordjournals.org/
D
ow
nloaded from
 
Results
Dopamine-Dependent Connectivity
We found multiple significant linear effects (L-dopa > placebo
> haloperidol) of dopaminergic drug group on cortico-
subcortical functional connectivity (cluster t > 2.3, P < 0.05,
FWE-corrected). These effects of connectivity greater in the
L-dopa group and reduced in the haloperidol group were ap-
parent between: (1) the posterocentric DMN and the midbrain
(peak t = 5.08; MNI coordinates: x =−6, y =−28, z =−6; see
Fig. 2A and Table 2 for full results); (2) the right-lateralized
(putative cognitive control; Vincent et al. 2008; Smith et al.
2009) FPN and the right dorsal caudate (t = 4.08; x = 12, y = 8,
z = 6; Fig. 2B); and (3) the inferior fronto-insular salience pro-
cessing/executive control RSN (Seeley et al. 2007; Smith et al.
2009) and the left ventral striatum (t = 4.21; x =−16, y = 12,
z =−10; Fig. 2C). (4) A significant drug effect was also found
on the connectivity between the left-lateralized FPN and
bilateral thalamic regions (Table 2). We found no significant
inverse linear effects (haloperidol > placebo > L-dopa) of dopa-
mine modulation on cortico-subcortical connectivity.
Associations with Impulsivity
We found that the dopamine-dependent connectivity between
the posterior DMN and the midbrain was significantly nega-
tively correlated with subject BIS-11 total scores in the halo-
peridol group (r =−0.58, P = 0.012, 2-tailed). Further, this
effect size was significantly different (z = 2.1, P = 0.038,
2-tailed) from an equivalent “positive” (nonsignificant) corre-
lation in the L-dopa group, thereby indicating an interaction
effect between impulsivity scores and drug type on network
functional connectivity (Fig. 2A). Although both haloperidol
and L-dopa groups were found to contain outliers, by remov-
ing the scores of these subjects from the respective connec-
tivity–impulsivity correlations, this interaction effect was
further amplified (z = 2.6, P = 0.010, 2-tailed). Of potential in-
terest, the drug effects on connectivity between the right FPN
and caudate showed an opposing relationship with BIS-11
scores to the midbrain-DMN pattern identified (Fig. 2B). No
within-group correlation reached significance for this FPN–
caudate relationship, but the haloperidol group correlation
was again opposite in direction to the other 2 groups and, in
this case, showed a trend toward a significant difference from
the BIS-11 correlation with the placebo group (z =−1.8,
P = 0.067, 2-tailed). The dopamine-dependent SEN-ventral
striatum connectivity pattern showed no within- or between-
group associations with BIS-11 scores (Fig. 2C).
Discussion
Our results provide a novel and important link between dopa-
mine neuromodulation and systems-level signaling within the
human brain. We demonstrate opposing effects of agonistic
and antagonistic dopaminergic challenges on functional con-
nectivity relationships between specific, dopamine-rich sub-
cortical regions and corresponding neocortical RSNs. Similar
large-scale neural circuits have been implicated in aspects of
cognition, personality, and reward processing relevant for
neuropsychiatric disorders commonly treated with dopamine-
targeting medications (e.g. Castellanos et al. 2008; Cole et al.
2010; Koob and Volkow 2010; Tost et al. 2010; Cole et al.
2011; Shannon et al. 2011; Wolf et al. 2011). We observe that
L-dopa generally increases cortico-subcortical network con-
nectivity in our study sample, whereas haloperidol tends to
decrease it. Furthermore, we show that acute dopamine antag-
onist modulation of cortico-striatal connectivity, identified
previously during task performance (Tost et al. 2010), is also
identifiable during rest and, intuitively, acts in opposition to
agonistic neuromodulatory effects. This suggests that RSN
functional connectivity can, in some cases, provide an indirect
measure of dopamine neurotransmission.
It is important to discuss the current results in the context
of existing neurobiological and neuropsychiatric findings. For
instance, the dopamine-dependent connectivity found here
between the ventral striatum and a “salience network,” cen-
tered on fronto-insular regions (Seeley et al. 2007), appears in
line with the proposed role for frontostriatal dopaminergic
mechanisms in mediating reward-related and motivated beha-
viors relevant for certain psychological functions and dysfunc-
tions (e.g. Pessiglione et al. 2006; Dagher and Robbins 2009;
Walter et al. 2009; Koob and Volkow 2010; Sesack and Grace
2010). In addition, the dopaminergic engagement of this
neural circuitry is implicated in symptoms of schizophrenia,
particularly aberrant salience processing, as well as their
augmentation with antipsychotic/neuroleptic drugs such as
haloperidol (Goldman-Rakic et al. 1989; Lidow and Goldman-
Rakic 1994; Horvitz 2000; Walter et al. 2009; for related
opinion, see also Menon 2011; Palaniyappan and Liddle
2012). Similarly, the dopamine-dependent integration of the
right caudate within the right-lateralized FPN found here is in
line with the proposed role for this circuitry in processes of
cognitive control, which has been highlighted using multiple
complementary approaches (Alexander et al. 1986; Goldman-
Rakic et al. 1989; Liston et al. 2006; Lungu et al. 2007; Cools
2008). Finally, dopamine-dependent connectivity with the
posterior DMN was found in posterior regions of the mid-
brain. This cluster overlaps only minimally with more anterior
regions regarded as the “dopaminergic midbrain,” such as the
substantia nigra or ventral tegmental area (which contain
major dopamine neuronal projections to and from anterior
subcortical and cortical circuitry; see e.g. Everitt and Robbins
2005). The Talairach Daemon atlas (Lancaster et al. 2000),
which was used here as a basis for defining the midbrain
portion of initial seed masks, labels this region predominantly
as, simply, “midbrain.” In fact, the cluster primarily covers
bilateral portions of the superior colliculi and periaqueductal
gray (although extending somewhat into left substantia nigra
and red nucleus, as defined by the Talairach Daemon atlas).
Interestingly, direct anatomical connections have been re-
ported between the precuneus (a central node of the posterior
DMN) and the superior colliculi (Cavanna and Trimble 2006)
and also between the latter and the substantia nigra (Comoli
et al. 2003). Importantly, the increased sensitivity of func-
tional connectivity methods to polysynaptic connectivity
relationships provides complementary information to that
achievable in studies of anatomical connectivity (Honey et al.
2009; Lu et al. 2011). Consistent with both this prior anatom-
ical evidence and the current dopamine-dependent functional
connectivity results, the superior colliculi have also been im-
plicated in a number of behavioral functions related to dopa-
minergic activity, particularly the processing of salient stimuli
(Comoli et al. 2003; Coizet et al. 2006; Krebs et al. 2012). Fur-
thermore, evidence of both periaqueductal gray and red
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nucleus involvement in large-scale networks implicated in
similar processes has been provided through prior studies of
functional connectivity (Seeley et al. 2007; Nioche et al.
2009). Future work may seek to delineate more directly each
of these cortico-subcortical RSN connectivity relationships in
terms of specific behavioral correlates sensitive to dopamine
modulation.
We note here that the levels of anatomical specificity
suggested earlier, particularly with regard to the midbrain,
should not be interpreted as definitive, as the whole-brain cov-
erage required for this FMRI study comes at the expense of fine-
grained spatial resolution at the level of some subcortical
nuclei. Future work using the latest imaging hardware at higher
magnetic field strengths (e.g. 7 T), coupled with further devel-
opment of acquisition sequences and physiological noise cor-
rection techniques optimized for obtaining BOLD signal in, for
example, the midbrain (Limbrick-Oldfield et al. 2012), will un-
doubtedly increase the spatial resolution achievable with whole-
brain imaging and thus should provide greater insight into sub-
cortical functional connectivity within large-scale networks.
Aside from the gross linear effects of dopaminergic pharma-
cological challenges on systems-level functioning, we also
identify selective associations between individual responses to
dopamine modulation of cortico-subcortical network connec-
tivity patterns and impulsive personality traits. The predictive
strength and the direction of these patterns differ depending
on the RSN involved, perhaps reflecting distinct network func-
tions (Beckmann et al. 2005; Seeley et al. 2007; Smith et al.
2009). For example, the DMN and FPN are thought to sub-
serve opposing aspects of cognition, but are seldom related
directly to impulsivity, although meta-analytic work strongly
implicates the right-lateralized FPN in inhibitory control
(Smith et al. 2009). Here, we expand on previous evidence by
highlighting that dopaminergic network differences in impul-
sivity extend beyond the midbrain and basal ganglia (Dalley
et al. 2007; Buckholtz et al. 2010) to large-scale, functionally
dissociable neocortical systems.
Moreover, it seems that subject impulsivity correlates more
strongly with the effects of haloperidol, relative to L-dopa, on
connectivity. The neurobiological reasons for this are unclear,
but may relate to pharmacological differences between the
drugs in specificity or potency. Administering exogenous
L-dopa indirectly increases neurotransmission by raising exist-
ing levels of the dopamine precursor, a process that may have
knock-on effects on other neurotransmitter systems (Everett
and Borcherding 1970; Dolphin et al. 1976). Conversely,
acute haloperidol challenge preferentially blocks neurotrans-
mission at dopamine D2 receptors and is thought to suppress
mechanisms governing synaptic plasticity, an effect likely to
be reflected in functional connectivity measures (Tost et al.
2010). Our findings raise the possibility that markers of im-
pulsive personality may primarily influence (or be influenced
by) these latter, more specific, dopaminergic mechanisms.
Indeed, by impacting a broader range of neurochemical
systems, L-dopa administration may influence a broader range
of behavioral functions with reduced specificity. Nonetheless,
we note here that dopamine D2 receptors are implicated in
numerous functions other than mediating individual differ-
ences in impulsivity, and thus their comparatively specific
modulation with haloperidol may also influence functions
not addressed in the current study, such as locomotion,
reward-based learning, and motivational processing (Volkow
et al. 1999; Vallone et al. 2000; Wise 2004; Johnson and
Kenny 2010). Alternatively, in a neuroleptic-naive population,
genetic, metabolic, or neurophysiological differences in sus-
ceptible individuals may increase sensitivity to novel dopa-
mine antagonism with clinical doses of haloperidol more
dramatically than sensitivity to indirect agonism with the
naturally present L-dopa molecule. This may be only indirectly
related to high trait impulsivity, although equivalent inter-
actions have previously been identified between impulsivity
differences and the functional effects of “direct” dopamine
agonists (Cools et al. 2007; Dalley et al. 2007). It should be
noted that the objectivity of the BIS-11 self-report scale in as-
sessing multifactorial impulsivity is a subject of some debate
(reviewed in Evenden 1999), although as a general construct
it displays robust inverse associations with molecular imaging
measures of D2/D3 receptor availability pertinent to subcorti-
cal dopamine neurotransmission (Buckholtz et al. 2010).
Our study incorporated a between-subjects design examin-
ing 3 pharmacological conditions in separate groups. As we
investigated connectivity in 2 distinct drug conditions and a
placebo condition, the envisaged practical benefits of requir-
ing only 1 scanning visit from each participant, rather than
requiring the same participant to be scanned on 3 occasions
under different conditions, were clearly realized in terms of
minimizing subject attrition. However, in many cases, within-
subject, double-blind, placebo-controlled studies are regarded
as preferable for increasing sensitivity to drug effects. Indeed,
it is possible that the additional between-group variability re-
sulting from our design decreases sensitivity to detecting
certain types of effect. Nevertheless, our analyses were sensi-
tive enough to reveal the significant systems-level pharmaco-
logical effects described. Furthermore, possible differences in
the potency of drug effects (at clinical doses) and the subjec-
tive psychological experiences thereof might introduce
additional order effect biases, even into the results of a ran-
domized design with repeated-measures within-subject.
Indeed, some of the apparent divergence between the current
findings and those of Kelly et al. (2009), who also tested the
effects of L-dopa drug modulation on functional connectivity,
may be explained by the fact that their study employed a
within-subject, placebo-controlled design. In addition, this
previous study used only a single pharmacological (L-dopa)
challenge and thus was unable to test hypotheses identical to
those examined in our study, specifically of linear dopamine
neuromodulatory effects on RSN connectivity (i.e. L-dopa >
placebo > haloperidol). Finally, these studies used quite
different analytical techniques to define “networks” of func-
tional connectivity. Thus, there are a number of reasons why
the 2 approaches are likely to be sensitive to distinct
systems-level effects of dopamine modulation. Nonetheless, it
will be important for future work to extend the approach de-
scribed here to elucidate differential drug effects on network
connectivity within individuals, particularly with the aim of
applying these techniques in clinical or medicines develop-
ment settings. Ideally, such extensions will also provide the
opportunity to obtain, pre- and post-drug administration, be-
havioral and other measures relevant for individual differ-
ences or neuropsychiatric disorders. This will enable
experimenters to interpret associations, such as those
between impulsivity and dopamine-dependent connectivity,
more directly in terms of changes over time or following
experimental intervention.
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In summary, we find cortico-subcortical network functional
connectivity patterns to be affected differentially by dopamine
agonist (L-dopa) and antagonist (haloperidol) drugs regularly
used to treat neuropsychiatric disorders, relative to a placebo.
The systems-level brain response to targeted pharmacological
D2 receptor blockade with a selective antagonist may be a
more sensitive endophenotype for certain neuropsychiatric
indications, such as trait impulsivity, than the response to
indirectly increasing dopamine neurotransmission by raising
precursor levels. Future studies could extend systems-level
investigation of cortico-subcortical connectivity associations
with personality, behavioral, or genetic factors to patient
populations regularly medicated with selective dopamine
receptor agonists or antagonists (Schafer et al. 2001; Dagher
and Robbins 2009), revealing the possible impact of brain
network functional interactions dependent on these factors
on treatment and prognosis.
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